Optimer Pharmaceuticals (OPTR) announces positive results from a pair of Phase 3 trials on the...

|About: Optimer Pharmaceuticals, ... (OPTR)|By:, SA News Editor

Optimer Pharmaceuticals (OPTR) announces positive results from a pair of Phase 3 trials on the benefits of its fidaxomicin tablets compared to oral vancomycin for cancer patients.